Home

Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA)

2.8800
-0.2600 (-8.28%)

Sonoma Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of solutions for dermatology and wound care

The company specializes in creating novel, prescriptive and over-the-counter formulations that utilize its patented technology to produce therapeutic products aimed at treating various skin conditions, infections, and wounds. By leveraging advanced science and research, Sonoma Pharmaceuticals aims to enhance patient outcomes and improve the quality of care in the healthcare sector, prioritizing safety and efficacy in its product offerings.

SummaryNewsPress ReleasesChartHistoricalFAQ